II.1)
Scope of the procurement
CHI invites tenders via an open competitive tender process for the provision of an analyser (s) to replace current in use instruments in the National Newborn Bloodspot Screening Laboratory
Reference number:
CHITSNNBSLAB2020 001
Supplies
II.1.4)
Short description
This TENDER document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s) to replace current in use instrument(s) in the National Newborn Bloodspot Screening Laboratory (NNBSL) at Children's Health Ireland (CHI) at Temple Street, Temple Street, Dublin 1.
Tender incorporates a system which MUST be capable at a minimum of performing the following Newborn Bloodspot Screens (NBS) on 3.2 mm dried blood spot (DBS) samples.
1. Congenital Hypothyroidism (CHT) screening by thyroid stimulating hormone (TSH) measurement
2. Cystic Fibrosis (CF) screening by immunoreactive trypsinogen (IRT) measurement
3. Galactosaemia screening by
• Total galactose (galactose and galactose-1-phosphate) and
• Galactose-1-phosphate uridyl transferase enzyme (GALT) analysis
Must interfacable toSpecimen Gate™.
All associated consumable must also be included within submission.
II.1.5)
Estimated total value
Value excluding VAT: 400000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2.2)
Additional CPV code(s)
33696500
-
Laboratory reagents
II.2.3)
Place of performance
Main site or place of performance:
CHI TEMPLE STREET DUBLIN
II.2.4)
Description of the procurement
This TENDER document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s) to replace current in use instrument(s) in the National Newborn Bloodspot Screening Laboratory (NNBSL) at Children's Health Ireland (CHI) at Temple Street, Temple Street, Dublin 1.
Tender incorporates a system which MUST be capable at a minimum of performing the following Newborn Bloodspot Screens (NBS) on 3.2 mm dried blood spot (DBS) samples.
1. Congenital Hypothyroidism (CHT) screening by thyroid stimulating hormone (TSH) measurement
2. Cystic Fibrosis (CF) screening by immunoreactive trypsinogen (IRT) measurement
3. Galactosaemia screening by
• Total galactose (galactose and galactose-1-phosphate) and
• Galactose-1-phosphate uridyl transferase enzyme (GALT) analysis
Must interfacable toSpecimen Gate™.
All associated consumable must also be included within submission.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 400000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
60
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no